  |
Related Articles |
Caregivers’ Priorities and Observed Outcomes of Attention-Deficit Hyperactivity Disorder Medication for Their Children.
J Dev Behav Pediatr. 2018 Feb/Mar;39(2):93-100
Authors: Ross M, Nguyen V, Bridges JFP, Ng X, Reeves G, Frosch E, dosReis S
Abstract
OBJECTIVE: To document variability among caregivers’ priorities when considering medication to treat their Children’s attention-deficit hyperactivity disorder (ADHD) and explore associations between these priorities and medication-related improvements.
METHODS: Caregivers of children, ages 4 to 14 years, diagnosed with ADHD were recruited from outpatient clinics and support groups across Maryland. A survey gathered data on caregiver-reported concerns when considering ADHD medication, demographic characteristics, and observed and desired improvements in their child’s ADHD. A validated Best-Worst Scaling instrument assessed priorities among 16 concerns when considering ADHD medication. Latent class analysis identified subgroups with similar ADHD medication concerns. Differences in self-reported medication-related improvements were examined across subgroups.
RESULTS: The 184 participants (mean = 42 yrs) were primarily the biological mother, 68% white and 25% black. Their children were mostly male (73%) and using medication (81%). Overall, the most important ADHD medication concerns were the child becoming a successful adult (p < 0.0001), school behavior improvements (p < 0.0001), and better grades (p < 0.0001). Others thinking badly of the child was a significantly less important concern (p < 0.0001). Three subgroups were identified: short-term outcomes-oriented group (39%), long-term outcomes-oriented group (37%), and side effects/safety-oriented group (27%). Relative to the other 2 groups, a smaller proportion of the side effects/safety-oriented group desired these improvements (p < 0.2618).
CONCLUSION: Most caregivers prioritize short- and long-term outcomes when considering ADHD medication. However, those most concerned with long- or short-term outcomes tended to desire additional improvements in their child’s ADHD.
PMID: 29461996 [PubMed – indexed for MEDLINE]
via https://www.ncbi.nlm.nih.gov/pubmed/29461996?dopt=Abstract